Skip to content

Treatment of Lateral Epicondylalgia With Shock Waves

Radial Shock Waves Versus Focal Shock Waves in the Treatment of Lateral Epicondylalgia

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT06587412
Enrollment
50
Registered
2024-09-19
Start date
2025-03-12
Completion date
2027-06-20
Last updated
2026-06-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Epicondylitis, Lateral, Epicondylitis of the Elbow

Brief summary

Lateral epicondylalgia (LET) is characterized by pain, decreased muscle strength of the wrist extensor muscles, and disability. Among the treatments proposed in the literature, both focal shockwave therapy and radial shockwave therapy have been considered effective in the management of this musculoskeletal disorder. The objective of this study is to compare the safety and effectiveness of these two shockwave applications on the signs and symptoms of subjects with lateral epicondylalgia. In this clinical trial, subjects will be evaluated for elbow pain using a Visual Analog Scale (VAS), grip strength using a handheld dynamometer, and degree of disability using the Patient-Rated Tennis Elbow Evaluation Questionnaire (PRTEE). A six-month follow-up will be performed. Patients will be randomly divided into three groups. The first group will receive radial shock waves (rESWT), the second group will receive focal shock waves (fESWT), and the third group, which will act as a control, will receive a placebo treatment with very low energy parameters according to the literature. Subjects will receive three sessions, one session per week.

Interventions

OTHERRadial shock waves treatment

Subjects in this group will receive radial shock waves

OTHERFocal Shock Waves treatment

Subjects in this group will receive focal shock waves

OTHERshock waves placebo treatment

Subjects in this group will receive a shock waves placebo treatment with very low energy settings

Sponsors

University of Alcala
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
TRIPLE (Subject, Investigator, Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
18 Years to 70 Years
Healthy volunteers
No

Inclusion criteria

* Pain in the lateral epicondyle \>3 months * Pain when performing resisted grip * Positive Cozen test * Positive Maudsley test

Exclusion criteria

* Pregnancy * Systemic diseases (Fibromyalgia, Diabetes, Arthritis) * Local infection or Cancer * Recent treatments (Physiotherapy, Corticosteroids)-

Design outcomes

Primary

MeasureTime frameDescription
Pain with Visual Analogue Scale (VAS)Change from Baseline pain at 6 monthThe pain VAS is a unidimensional measure of pain intensity, used to record patients' pain progression. VAS is a straight horizontal line of fixed length, usually 100 mm. The ends are defined as the extreme limits of the parameter to be measured where "0" on the far left is no pain and "10" on the far right is the worst pain possible.

Secondary

MeasureTime frameDescription
Grip strengthChange from Baseline pain at 6 monthGrip strength is a measure of muscular strength or the maximum force/tension generated by one's forearm muscles. It will be recorded using a hand-held dynamometer. The subject is asked to exert grip strength until pain appears. It is measured in newtons.
Patient Rated Tennis Elbow Evaluation (PRTEE)Change from Baseline pain at 6 monthThe PRTEE is a population specific 15-item questionnaire designed to measure forearm pain and disability associated with lateral epicondyle tendinopathy. 0% is the best and 100% is the worst disability outcome
The Global Rating of Change (GROC)Change from Baseline pain at 6 monthIt's a scale that assesses whether the patient condition has gotten worse, better, or stayed the same and to quantify the magnitude of that change, typically following treatment.Subjects will make global ratings of changes regarding their level of well-being from their neck pain since the initial examination on a 15-point self-report scale (from -7 to 7), where -7 is the worst possible value and 7 is the best possible value.

Countries

Spain

Contacts

CONTACTYanira Rodriguez-García, Master
yanira.rodriguez@edu.uah.es34 918855142

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Jun 3, 2026